UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-38109 MYOMO, INC. (Exact name of Registrant as Specified in its Charter) Delaware 47-0944526 (State or Other Jurisdiction ...

财务数据和关键指标变化 - 总收入为6百万美元,同比增长62%,其中产品收入4.2百万美元,同比增长15% [31][32] - 毛利率为71.8%,同比提升6.5个百分点,剔除许可费收入后毛利率为60.5%,同比下降近500个基点 [35] - 经营亏损为110万美元,同比改善1.8百万美元 [38] - 净亏损为100万美元,每股亏损0.04美元 [38] - 调整后EBITDA为负80万美元,同比改善1.7百万美元 [40] 各条业务线数据和关键指标变化 - 直接销售渠道占收入的79%,同比下降4个百分点 [33] - 国际收入占产品收入的12% [33] - 订单量增加23%至125台,交付量增加21%至97台 [32][34] - 订单平均售价下降5%至43,700美元 [32] 各个市场数据和关键指标变化 - 中国市场方面,合资公司已完成首批300万美元的控制系统订单,未来10年内将有1,075万美元的最低采购承诺 [12][15] - 澳大利亚市场也开始有患者通过国家残疾保险计划获得报销 [102] - 加拿大市场已取得医疗器械销售许可,正在与当地医疗保险系统对接报销事宜 [104] 公司战略和发展方向及行业竞争 - 公司正积极推进Medicare Part B的报销覆盖,预计2023年底或2024年初有望实现 [26][29] - 公司正在建立Medicare Part B患者的销售渠道和流程,以便在报销政策落地后快速服务这一大患者群体 [27] - 公司正在优化营销策略,2023年广告费用预计将减少200万美元 [37] - 公司正在拓展国际市场,尤其是德国和澳大利亚,并与中国合资公司加快在当地的布局 [100][101][102] 管理层对经营环境和未来前景的评论 - 管理层对公司在产品销售、运营效率和成本控制方面取得的进展表示满意 [8][11][37] - 管理层对Medicare Part B报销政策的落地持乐观态度,认为这将大幅扩大公司的潜在市场 [17][18][60] - 管理层表示将继续优化营销策略,提高销售效率,并积极拓展国际市场 [10][100][101] 问答环节重要的提问和回答 问题1 **Ben Haynor 提问** 为什么公司的患者管线大幅增加? [51] **Paul Gudonis 回答** 公司新增了"患者导航员"角色,加强了与患者的互动和沟通,帮助更多患者完成获取MyoPro的全流程 [52] 问题2 **Scott Henry 提问** Medicare Part B报销政策变化对公司的财务模式有何影响? [68][69] **Dave Henry 回答** 整体来看,采用一次性报销模式相比月租模式更有利于公司的现金流和财务状况 [70][71] 问题3 **Anthony Vendetti 提问** 公司目前的销售团队规模和未来的扩充计划如何? [87][88][92] **Paul Gudonis 回答** 公司目前有20名左右的全职员工,包括客户服务人员和认证的矫形师,未来随着Medicare Part B业务的增长还需要适当扩充团队 [92][93]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-38109 MYOMO, INC. (Exact name of Registrant as Specified in its Charter) Delaware 47-0944526 (State or Other Jurisdiction of (I ...

Myomo, Inc. (NYSE:MYO) Q1 2023 Results Conference Call May 10, 2023 4:30 PM ET Company Participants Kim Golodetz - Investor Relations, LHA Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Participants Ben Haynor - Alliance Global Partners Scott Henry - ROTH Capital Jim Sidoti - Sidoti & Company Edward Woo - Ascendant Capital Operator Good afternoon, and welcome to the Myomo First Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-38109 MYOMO, INC. (Exact name of Registrant as Specified in its Charter) Delaware 47-0944526 (State or Other Jurisdiction of ( ...

Table of Contents m UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-38109 MYOMO, INC. (Exact name of registrant as specified in its charter) Delaware 47-0944526 (State or other ju ...

Myomo, Inc (NYSE:MYO) Q4 2022 Earnings Conference Call March 13, 2023 10:00 AM ET Company Participants Kim Golodetz - Investor Relations, LHA Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Participants Jim Sidoti - Sidoti & Company Edward Woo - Ascendiant Capital Ben Haynor - Alliance Global Partners Jeremy Pearlman - Maxim Group Operator Good morning, and welcome to the Myomo, Inc. Fourth Quarter and Full Year 2022 Earnings Conference Call. All participants will ...